Stock Earnings

Question 1

What are Kalbe Farma Tbk PT's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Kalbe Farma Tbk PT has a total asset of $29,429,727, Net profit of $3,240,636

Question 2

What are the key financial ratios for PTKFY?

Accepted Answer

Kalbe Farma Tbk PT's Current ratio is 4.43, has a Net margin is 9.93, sales per share of $706.42.

Question 3

How is Kalbe Farma Tbk PT's revenue broken down by segment or geography?

Accepted Answer

Kalbe Farma Tbk PT largest revenue segment is Distribution and Logistic, at a revenue of 10,900,590,578,082 in the most earnings release.For geography, Indonesia is the primary market for Kalbe Farma Tbk PT, at a revenue of 30,823,642,050,717.

Question 4

Is Kalbe Farma Tbk PT profitable?

Accepted Answer

yes, according to the latest financial statements, Kalbe Farma Tbk PT has a net profit of $3,240,636

Question 5

Does Kalbe Farma Tbk PT have any liabilities?

Accepted Answer

yes, Kalbe Farma Tbk PT has liability of 6,640,848

Question 6

How many outstanding shares for Kalbe Farma Tbk PT?

Accepted Answer

Kalbe Farma Tbk PT has a total outstanding shares of 45,951.46

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	34,377,309	32,627,776	30,449,134	28,933,502	26,261,194	23,112,654
Revenue Growth (YoY)	7%	7%	5%	10%	14%	2%
Cost of Revenue	20,797,760	20,108,126	19,001,211	17,416,282	15,157,805	13,062,932
Gross Profit	13,579,549	12,519,649	11,447,923	11,517,220	11,103,389	10,049,722
Selling, General & Admin	7,847,690	7,133,875	6,699,877	6,313,077	6,074,547	5,530,132
Research & Development	727,106	702,779	575,712	438,318	493,371	441,755
Operating Expenses	9,233,207	8,452,203	7,822,786	7,294,709	7,108,104	6,495,826
Other Non Operating Income (Expenses)	-14,762	-12,914	-12,145	-13,833	-12,736	-21,715
Pretax Income	4,603,961	4,218,874	3,606,237	4,458,896	4,143,264	3,627,632
Income Tax Expense	1,058,957	972,304	827,832	1,008,813	911,256	828,010
Net Income	3,493,602	3,240,636	2,766,748	3,382,209	3,183,621	2,733,259
Net Income Growth	13%	17%	-18%	6%	16%	9%
Shares Outstanding (Diluted)	45,465.95	46,186.86	46,255.64	46,515.94	46,872.94	46,873.43
Shares Change (YoY)	-2%	0%	-1%	-1%	0%	0%
EPS (Diluted)	76.83	70.16	59.81	72.71	67.92	58.31
EPS Growth	15%	17%	-18%	7%	16%	9%
Free Cash Flow	2,615,752	3,534,843	1,729,123	401,788	1,825,076	3,096,540
Free Cash Flow Per Share	57.53	76.53	37.38	8.63	38.93	66.06
Gross Margin	39.5%	38.37%	37.59%	39.8%	42.28%	43.48%
Operating Margin	12.64%	12.46%	11.9%	14.59%	15.21%	15.37%
Profit Margin	10.16%	9.93%	9.08%	11.68%	12.12%	11.82%
Free Cash Flow Margin	7.6%	10.83%	5.67%	1.38%	6.94%	13.39%
EBITDA	4,765,457	4,461,116	4,006,438	4,604,010	4,375,344	3,926,811
EBITDA Margin	13.86%	13.67%	13.15%	15.91%	16.66%	16.98%
D&A For EBITDA	419,115	393,670	381,301	381,500	380,060	372,915
EBIT	4,346,342	4,067,446	3,625,137	4,222,510	3,995,284	3,553,896
EBIT Margin	12.64%	12.46%	11.9%	14.59%	15.21%	15.37%
Effective Tax Rate	23%	23.04%	22.95%	22.62%	21.99%	22.82%

Kalbe Farma Tbk PT (PTKFY) Price

PTKFY Stock Price Chart

PTKFY Income

Follow-Up Questions